HB Exhibits at the 2024 ISBT and China-Eurasia Expo

Date:2024-06-27
Pageviews:575

On June 27th, the 39th International Society of Blood Transfusion (ISBT) International Congress will be successfully concluded. As a global influential event in this field, this congress attracted transfusion medical professionals from over 100 countries. Haier Biomedical, a global leading provider of digital solutions for life sciences and medical innovation, showcased its latest technologies and solutions in intelligent blood management to the world, further enhancing its brand influence in the global market.


N 6.27-111.png


During the congress, Haier Biomedical presented various innovative products covering all aspects of blood management, which attracted numerous visitors with superior performance and advanced technology. A medical expert from Europe expressed, "Haier Biomedical's products are not only advanced in technology, but also meet the market demand for quality products. Haier Biomedical’s innovative solutions are important for enhancing our blood management."


N 6.27-12.png


Enhancing Brand Impact through Global Expansion!


In addition, Haier Biomedical also participated in the China-Eurasia Expo held in Urumchi from June 26th to 30th, showcasing its innovative solutions in medical technology. This exhibition provides Haier Biomedical with a platform to demonstrate its technological prowess and innovative capabilities, further strengthening its communication and cooperation with Eurasian countries, and advancing its global expansion strategy.


N 6-min.jpg


Leading the Industry with continuous Innovation!


Haier Biomedical is committed to providing high-quality medical equipment and solutions for global users. Looking ahead, Haier Biomedical will continue to drive innovation through technology and product quality enhancement. Additionally, with active engagement in more international exhibitions and industry interaction, Haier Biomedical will continue contribute to advancing global medical and healthcare efforts.